These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gene therapy for human liver disease. Raper SE; Wilson JM Prog Liver Dis; 1995; 13():201-30. PubMed ID: 9224503 [TBL] [Abstract][Full Text] [Related]
3. Cell transplantation in liver-directed gene therapy. Raper SE; Wilson JM Cell Transplant; 1993; 2(5):381-400; discussion 407-10. PubMed ID: 8162279 [TBL] [Abstract][Full Text] [Related]
4. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia. High KA Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929 [TBL] [Abstract][Full Text] [Related]
5. Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes. Morsy MA; Zhao JZ; Ngo TT; Warman AW; O'Brien WE; Graham FL; Caskey CT J Clin Invest; 1996 Feb; 97(3):826-32. PubMed ID: 8609240 [TBL] [Abstract][Full Text] [Related]
6. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Overturf K; Al-Dhalimy M; Tanguay R; Brantly M; Ou CN; Finegold M; Grompe M Nat Genet; 1996 Mar; 12(3):266-73. PubMed ID: 8589717 [TBL] [Abstract][Full Text] [Related]
7. The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency. Batshaw ML; Yudkoff M; McLaughlin BA; Gorry E; Anegawa NJ; Smith IA; Hyman SL; Robinson MB Gene Ther; 1995 Dec; 2(10):743-9. PubMed ID: 8750014 [TBL] [Abstract][Full Text] [Related]
8. [Intrasplenic transplantation of hepatocytes in spf-ash mice with congenital ornithine transcarbamylase deficiency]. Michel JL; Rabier D; Rambaud C; Kamoun P; Brousse N; Vassault A; Pla M; Calise D; Revillon Y Chirurgie; 1993-1994; 119(10):666-71. PubMed ID: 7729184 [TBL] [Abstract][Full Text] [Related]
10. [Current status of cell-based therapies in liver diseases]. Petersen J; Ott M; von Weizsäcker F Z Gastroenterol; 2001 Nov; 39(11):975-80. PubMed ID: 11778158 [TBL] [Abstract][Full Text] [Related]
11. Liver repopulation with hepatocyte transplantation: new avenues for gene and cell therapy. Gupta S; Malhi H; Gagandeep S; Novikoff P J Gene Med; 1999; 1(6):386-92. PubMed ID: 10753063 [TBL] [Abstract][Full Text] [Related]
12. Foreword: prospects of liver cell transplantation and liver-directed gene therapy. Chowdhury JR Semin Liver Dis; 1999; 19(1):1-6. PubMed ID: 10349678 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences. Chuah MK; Vandendriessche T Bull Mem Acad R Med Belg; 2007; 162(5-6):357-61. PubMed ID: 18405006 [TBL] [Abstract][Full Text] [Related]
14. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793 [TBL] [Abstract][Full Text] [Related]
17. Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequences. Chuah M; Vandendriessche T Verh K Acad Geneeskd Belg; 2007; 69(5-6):315-34. PubMed ID: 18351211 [TBL] [Abstract][Full Text] [Related]
18. Round two for liver gene therapy. Wilson JM Nat Genet; 1996 Mar; 12(3):232-3. PubMed ID: 8589710 [No Abstract] [Full Text] [Related]
20. Gene transfer as an approach to treating hemophilia. High KA Semin Thromb Hemost; 2003 Feb; 29(1):107-20. PubMed ID: 12640573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]